NCCN Celebrates Outstanding Contributions in Oncology with 2025 Awards
On May 28, 2025, the National Comprehensive Cancer Network® (NCCN®) announced its prestigious 2025 award recipients, recognizing individuals who have made extraordinary contributions to the field of oncology. These honorees have tirelessly worked to enhance quality, effective, equitable, and accessible cancer care worldwide, reflecting NCCN's mission to ensure that all individuals can lead healthier lives regardless of their circumstances.
Championing Quality Care
Crystal S. Denlinger, MD, CEO of NCCN, expressed pride in acknowledging those who advocate for high-quality, patient-centered cancer care globally. The 2025 awardees exemplify excellence, innovation, and collaboration, making them exemplary figures in oncology. Their dedication serves not only as inspiration for their peers but also highlights the importance of teamwork in combating cancer.
Excellence in Engagement Award Recipients
Among the distinguished awardees, two individuals received the Excellence in Engagement Award, which honors leaders within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panels. These individuals have demonstrated remarkable dedication and collaboration in shaping critical cancer treatment recommendations.
Nadeem R. Abu-Rustum, MD from Memorial Sloan Kettering Cancer Center was recognized for his extensive involvement with the NCCN Guidelines® Panel for Cervical/Uterine Cancers, where he has served since 2019. His efforts to adapt gynecologic guidelines globally have been instrumental, showcasing his unwavering commitment to patient safety and exemplary dedication to the mission set forth by NCCN.
“I am truly honored to receive the 2025 Excellence in Engagement Award,